Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bacterial Infections and Mycoses

  Free Subscription


26.02.2024

1 Am J Trop Med Hyg
1 Ann Intern Med
1 Antimicrob Agents Chemother
1 Biochemistry
1 BMC Pediatr
1 BMJ
1 Cancer
1 Chest
11 Clin Infect Dis
3 Eur J Clin Microbiol Infect Dis
1 J Antimicrob Chemother
1 J Bacteriol
5 J Infect Dis
4 J Med Microbiol
5 Lancet
2 MMWR Morb Mortal Wkly Rep
2 Nat Med
1 PLoS Med
1 PLoS Negl Trop Dis
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Trop Med Hyg

  1. ALI GA, Goravey W
    Disseminated Tuberculosis of the Axial Skeleton.
    Am J Trop Med Hyg. 2024 Feb 20:tpmd230691. doi: 10.4269/ajtmh.23-0691.
    PubMed        


    Ann Intern Med

  2. ZIMILOVER A, Glatt AE
    In nursing homes, universal decolonization vs. routine care reduced transfers to hospital for infection.
    Ann Intern Med. 2024;177:JC21.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  3. LI S-Y, Tyagi S, Soni H, Betoudji F, et al
    Bactericidal and sterilizing activity of novel regimens combining bedaquiline or TBAJ-587 with GSK2556286 and TBA-7371 in a mouse model of tuberculosis.
    Antimicrob Agents Chemother. 2024 Feb 20:e0156223. doi: 10.1128/aac.01562.
    PubMed         Abstract available


    Biochemistry

  4. CAMPOMIZZI CS, Uttamrao PP, Stallone JJ, Rathinavelan T, et al
    Asparagine-85 Stabilizes a Structural Active Site Water Network in CYP121A1 of Mycobacterium tuberculosis.
    Biochemistry. 2024 Feb 21. doi: 10.1021/acs.biochem.3c00555.
    PubMed         Abstract available


    BMC Pediatr

  5. ALTASEB T, Lingerew M, Adane M
    Prevalence of trachomatous inflammation-follicular and associated factors among children aged 1-9 years in northeastern Ethiopia.
    BMC Pediatr. 2024;24:128.
    PubMed         Abstract available


    BMJ

  6. TANNE JH
    Maternal syphilis rates tripled in the US between 2016 and 2022, data show.
    BMJ. 2024;384:q416.
    PubMed        


    Cancer

  7. NOOKA AK, Rodriguez C, Mateos MV, Manier S, et al
    Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study.
    Cancer. 2023 Nov 14. doi: 10.1002/cncr.35107.
    PubMed         Abstract available


    Chest

  8. GODET C, Brun AL, Couturaud F, Laurent F, et al
    CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma.
    Chest. 2024 Feb 20:S0012-3692(24)00261-7. doi: 10.1016/j.chest.2024.
    PubMed         Abstract available


    Clin Infect Dis

  9. PROSTY C, Hanula R, Katergi K, Longtin Y, et al
    Clinical Outcomes and Management of NAAT-Positive/Toxin-Negative Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2024;78:430-438.
    PubMed         Abstract available

  10. WALKER J, McCarty T, McGwin G, Ordaya EE, et al
    Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey through the Mycosis Study Group Education and Research Consortium (MSG-19).
    Clin Infect Dis. 2023 Sep 15:ciad551. doi: 10.1093.
    PubMed         Abstract available

  11. TUNKEL AR
    Cefazolin for the Treatment of Central Nervous System Infections.
    Clin Infect Dis. 2024;78:489-490.
    PubMed        

  12. WANG M, Ge L, Chen L, Komarow L, et al
    Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Acinetobacter baumannii Among Patients from Different Global Regions.
    Clin Infect Dis. 2023 Sep 20:ciad556. doi: 10.1093.
    PubMed         Abstract available

  13. HOWARD-ANDERSON J, Hamasaki T, Dai W, Collyar D, et al
    Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
    Clin Infect Dis. 2024;78:259-268.
    PubMed         Abstract available

  14. BAMPOE VD, Brown N, Deng L, Schiffer J, et al
    Serologic Immunity to Tetanus in the United States, National Health and Nutrition Examination Survey, 2015-2016.
    Clin Infect Dis. 2024;78:470-475.
    PubMed         Abstract available

  15. RAO K, Zhao Q, Bell J, Krishnan J, et al
    An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections.
    Clin Infect Dis. 2024;78:277-282.
    PubMed         Abstract available

  16. PERI AM, O'Callaghan K, Rafiei N, Graves B, et al
    Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications.
    Clin Infect Dis. 2024;78:283-291.
    PubMed         Abstract available

  17. TINGSGARD S, Bastrup Israelsen S, Ostergaard C, Benfield T, et al
    Emulating a Target Trial of Shorter Compared to Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia.
    Clin Infect Dis. 2024;78:292-300.
    PubMed         Abstract available

  18. KLINE MC, Kissler SM, Whittles LK, Barnett ML, et al
    Spatiotemporal Trends in Group A Streptococcal Pharyngitis in the United States.
    Clin Infect Dis. 2024 Feb 19:ciae083. doi: 10.1093.
    PubMed         Abstract available

  19. KARMARKAR EN, Fitzpatrick T, Himmelfarb ST, Chow EJ, et al
    Cluster of non-toxigenic Corynebacterium diphtheriae infective endocarditis and rising background C. diphtheriae cases-Seattle, Washington 2020-2023.
    Clin Infect Dis. 2024 Feb 21:ciae094. doi: 10.1093.
    PubMed         Abstract available


    Eur J Clin Microbiol Infect Dis

  20. CAO X, Guo T, Xin H, Du J, et al
    Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study.
    Eur J Clin Microbiol Infect Dis. 2024 Feb 22. doi: 10.1007/s10096-024-04777.
    PubMed         Abstract available

  21. DIEZ-VIDAL A, Gonzalez-Garcia ME, Marco-Clement I, Azores-Moreno J, et al
    Recurrent bacteremia and endocarditis due to Staphylococcus capitis in a patient with Bowen's disease: a case report.
    Eur J Clin Microbiol Infect Dis. 2024 Feb 20. doi: 10.1007/s10096-024-04783.
    PubMed         Abstract available

  22. RANI V, Aye NK, Saksena R, Dabi KC, et al
    Risk factors and outcome associated with the acquisition of MDR linezolid-resistant Enterococcus faecium: a report from tertiary care centre.
    Eur J Clin Microbiol Infect Dis. 2024 Feb 19. doi: 10.1007/s10096-024-04784.
    PubMed         Abstract available


    J Antimicrob Chemother

  23. BRENCIANI A, Cinthi M, Coccitto SN, Massacci FR, et al
    Global spread of the linezolid-resistant Enterococcus faecalis ST476 clonal lineage carrying optrA.
    J Antimicrob Chemother. 2024 Feb 15:dkae039. doi: 10.1093.
    PubMed         Abstract available


    J Bacteriol

  24. ZHANG J-J, Raghunandanan S, Wang Q, Priya R, et al
    BadR directly represses the expression of the glycerol utilization operon in the Lyme disease pathogen.
    J Bacteriol. 2024;206:e0034023.
    PubMed         Abstract available


    J Infect Dis

  25. KAPIL P, Wang Y, Zimmerman L, Gaykema M, et al
    "Repeated B. pertussis Infections are Required to Reprogram Acellular Pertussis Vaccine-primed Host Responses in the Baboon Model".
    J Infect Dis. 2023 Aug 11:jiad332. doi: 10.1093.
    PubMed         Abstract available

  26. SUNDERMANN AJ, Rangachar Srinivasa V, Mills EG, Griffith MP, et al
    Two Artificial Tears Outbreak-Associated Cases of Extensively Drug-Resistant Pseudomonas aeruginosa Detected Through Whole Genome Sequencing-Based Surveillance.
    J Infect Dis. 2024;229:517-521.
    PubMed         Abstract available

  27. BASU THAKUR P, Mrotz VJ, Maines TR, Belser JA, et al
    Ferrets as a mammalian model to study influenza virus-bacteria interactions.
    J Infect Dis. 2023 Sep 22:jiad408. doi: 10.1093.
    PubMed         Abstract available

  28. OH IS, Kim JH, Huh K, Jang SH, et al
    Impact of National Public-Private Mix and Medical Expense Support Program for Control Tuberculosis in South Korea: An Interrupted Time Series Analysis.
    J Infect Dis. 2024 Feb 14:jiae059. doi: 10.1093.
    PubMed         Abstract available

  29. YAGLOM HD, Bhattarai R, Lemmer D, Rust L, et al
    Large Clusters of Invasive emm49 Group A Streptococcus Identified within and across Arizona Healthcare Facilities through Statewide Genomic Surveillance System, 2019-2021.
    J Infect Dis. 2024 Feb 19:jiae086. doi: 10.1093.
    PubMed         Abstract available


    J Med Microbiol

  30. DA SILVA CR, Reboucas JDO, Cabral VPF, Rodrigues DS, et al
    Promising activity of etomidate against mixed biofilms of fluconazole-resistant Candida albicans and methicillin-resistant Staphylococcus aureus.
    J Med Microbiol. 2024;73.
    PubMed         Abstract available

  31. MOHAMAD AZRANYI M, Aziz ZA, Ishak D, Mohd Nais NF, et al
    Five-year species distribution and antimicrobial susceptibility of non-tuberculous mycobacteria in Malaysia, 2018-2022.
    J Med Microbiol. 2024;73.
    PubMed         Abstract available

  32. TAYLOR GM, White-Iribhogbe K, Cole G, Ashby D, et al
    Bioarchaeological investigation of individuals with suspected multibacillary leprosy from the mediaeval leprosarium of St Mary Magdalen, Winchester, Hampshire, UK.
    J Med Microbiol. 2024;73.
    PubMed         Abstract available

  33. AMBREETHA S, Zincke D, Balachandar D, Mathee K, et al
    Genomic and metabolic versatility of Pseudomonas aeruginosa contributes to its inter-kingdom transmission and survival.
    J Med Microbiol. 2024;73.
    PubMed         Abstract available


    Lancet

  34. KIMBALL AB, Ravichandran S
    Secukinumab treatment of hidradenitis suppurativa: questions remain - Authors' reply.
    Lancet. 2024;403:617-618.
    PubMed        

  35. ENDO M, Kami M
    Secukinumab treatment of hidradenitis suppurativa: questions remain.
    Lancet. 2024;403:617.
    PubMed        

  36. MAUL JT, Kolios AGA, Thomsen SF, Ring HC, et al
    Secukinumab treatment of hidradenitis suppurativa: questions remain.
    Lancet. 2024;403:616-617.
    PubMed        

  37. PETERS RPH, Klausner JD, Mazzola L, Mdingi MM, et al
    Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation.
    Lancet. 2024;403:657-664.
    PubMed         Abstract available

  38. PAI NP, Dillon JR
    A lateral flow assay for Neisseria gonorrhoeae: a step forward for an inexpensive biomarker-based diagnosis of N gonorrhoeae at the point of care?
    Lancet. 2024;403:594-595.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  39. EDENS C, Clopper BR, DeVies J, Benitez A, et al
    Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:149-151.
    PubMed        

  40. KUGELER KJ, Earley A, Mead PS, Hinckley AF, et al
    Surveillance for Lyme Disease After Implementation of a Revised Case Definition - United States, 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:118-123.
    PubMed         Abstract available


    Nat Med

  41. O'LEARY K
    Digital intervention improves tuberculosis treatment outcomes.
    Nat Med. 2024 Feb 19. doi: 10.1038/d41591-024-00009.
    PubMed        

  42. DIACON AH, Barry CE 3rd, Carlton A, Chen RY, et al
    A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.
    Nat Med. 2024 Feb 16. doi: 10.1038/s41591-024-02829.
    PubMed         Abstract available


    PLoS Med

  43. SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
    Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
    PLoS Med. 2024;21:e1004356.
    PubMed         Abstract available


    PLoS Negl Trop Dis

  44. HOODA Y, Islam S, Kabiraj R, Rahman H, et al
    Old tools, new applications: Use of environmental bacteriophages for typhoid surveillance and evaluating vaccine impact.
    PLoS Negl Trop Dis. 2024;18:e0011822.
    PubMed         Abstract available


    PLoS One

  45. KIM D, Moon JS, Kim JE, Jang YJ, et al
    Evaluation of purine-nucleoside degrading ability and in vivo uric acid lowering of Streptococcus thermophilus IDCC 2201, a novel antiuricemia strain.
    PLoS One. 2024;19:e0293378.
    PubMed         Abstract available

  46. CHAVAN VV, Dalal A, Nagaraja S, Thekkur P, et al
    Correction: Ambulatory management of pre- and extensively drug resistant tuberculosis patients with imipenem delivered through port-a-cath: A mixed methods study on treatment outcomes and challenges.
    PLoS One. 2024;19:e0299477.
    PubMed         Abstract available

  47. ADAMU Y, Puig-Asensio M, Dabo B, Schweizer ML, et al
    Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.
    PLoS One. 2024;19:e0293423.
    PubMed         Abstract available

  48. DAY AW, Kumamoto CA
    Selection of ethanol tolerant strains of Candida albicans by repeated ethanol exposure results in strains with reduced susceptibility to fluconazole.
    PLoS One. 2024;19:e0298724.
    PubMed         Abstract available

  49. JONES J, Shi Q, Nath RR, Brito IL, et al
    Keystone pathobionts associated with colorectal cancer promote oncogenic reprograming.
    PLoS One. 2024;19:e0297897.
    PubMed         Abstract available

  50. CANPOLAT ERKAN RE, Tekin R
    Investigation of new inflammatory biomarkers in patients with brucella.
    PLoS One. 2024;19:e0297550.
    PubMed         Abstract available

  51. KOIDE K, Uchitani Y, Yamaguchi T, Otsuka N, et al
    Whole-genome comparison of two same-genotype macrolide-resistant Bordetella pertussis isolates collected in Japan.
    PLoS One. 2024;19:e0298147.
    PubMed         Abstract available

  52. MAFIZUR RM, Sangjin L, Chul PY
    Prevalence of Salmonella spp. and Escherichia coli in the feces of free-roaming wildlife throughout South Korea.
    PLoS One. 2024;19:e0281006.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.